202 related articles for article (PubMed ID: 12227860)
1. Continuous glucose monitoring and haemoglobin A(1c).
Sharp P; Rainbow S
Ann Clin Biochem; 2002 Sep; 39(Pt 5):516-7. PubMed ID: 12227860
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.
Kaufman FR; Gibson LC; Halvorson M; Carpenter S; Fisher LK; Pitukcheewanont P
Diabetes Care; 2001 Dec; 24(12):2030-4. PubMed ID: 11723078
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study).
Cooke D; Hurel SJ; Casbard A; Steed L; Walker S; Meredith S; Nunn AJ; Manca A; Sculpher M; Barnard M; Kerr D; Weaver JU; Ahlquist J; Newman SP
Diabet Med; 2009 May; 26(5):540-7. PubMed ID: 19646195
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial factors associated with use of continuous glucose monitoring.
Ritholz MD; Atakov-Castillo A; Beste M; Beverly EA; Leighton A; Weinger K; Wolpert H
Diabet Med; 2010 Sep; 27(9):1060-5. PubMed ID: 20722681
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin Glycosylation Index is not related with blood glucose.
Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
[TBL] [Abstract][Full Text] [Related]
7. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
8. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.
Cosson E; Hamo-Tchatchouang E; Dufaitre-Patouraux L; Attali JR; Pariès J; Schaepelynck-Bélicar P
Diabetes Metab; 2009 Sep; 35(4):312-8. PubMed ID: 19560388
[TBL] [Abstract][Full Text] [Related]
9. [Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication].
Borg R; Nerup J; Nathan DM; Kuenen J; Zheng H; Schoenfeld D; Heine RJ;
Ugeskr Laeger; 2009 Nov; 171(45):3262-5. PubMed ID: 19916193
[TBL] [Abstract][Full Text] [Related]
10. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
11. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
12. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
13. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
[TBL] [Abstract][Full Text] [Related]
14. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
Pickup JC; Kidd J; Burmiston S; Yemane N
Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
[TBL] [Abstract][Full Text] [Related]
15. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community.
Shemesh T; Piers LS; O'Dea K
Ann Clin Biochem; 2003 Sep; 40(Pt 5):566-8. PubMed ID: 14503997
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
; Wilson DM; Xing D; Beck RW; Block J; Bode B; Fox LA; Hirsch I; Kollman C; Laffel L; Ruedy KJ; Steffes M; Tamborlane WV
Diabetes Care; 2011 Mar; 34(3):540-4. PubMed ID: 21266647
[TBL] [Abstract][Full Text] [Related]
17. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study.
Halimi S; Charpentier G; Grimaldi A; Grenier JL; Baut F; Germain B; Magnette J
Diabetes Metab; 2001 Dec; 27(6):681-7. PubMed ID: 11852377
[TBL] [Abstract][Full Text] [Related]
18. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
19. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.
Bonora E; Calcaterra F; Lombardi S; Bonfante N; Formentini G; Bonadonna RC; Muggeo M
Diabetes Care; 2001 Dec; 24(12):2023-9. PubMed ID: 11723077
[TBL] [Abstract][Full Text] [Related]
20. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.
Kovatchev BP; Cox DJ; Kumar A; Gonder-Frederick L; Clarke WL
Diabetes Technol Ther; 2003; 5(5):817-28. PubMed ID: 14633347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
